Duncker Streett & Co. Inc. Sells 974 Shares of UnitedHealth Group Incorporated (UNH)

Duncker Streett & Co. Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 32.2% during the second quarter, Holdings Channel reports. The institutional investor owned 2,048 shares of the healthcare conglomerate’s stock after selling 974 shares during the period. Duncker Streett & Co. Inc.’s holdings in UnitedHealth Group were worth $380,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC boosted its stake in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares in the last quarter. Kings Point Capital Management boosted its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management acquired a new stake in shares of UnitedHealth Group during the first quarter worth about $135,000. Finally, Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares in the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) traded down 0.61% on Friday, hitting $191.53. 1,459,494 shares of the stock were exchanged. The company has a 50-day moving average price of $190.34 and a 200-day moving average price of $175.66. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04. The firm has a market capitalization of $185.18 billion, a PE ratio of 23.01 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.96 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

TRADEMARK VIOLATION NOTICE: This news story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/08/18/duncker-streett-co-inc-sells-974-shares-of-unitedhealth-group-incorporated-unh.html.

A number of brokerages recently issued reports on UNH. UBS AG reiterated a “buy” rating and issued a $194.00 price objective (up from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cowen and Company reiterated an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Jefferies Group LLC reiterated a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a report on Friday. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, June 9th. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $203.41.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock valued at $2,873,320 in the last three months. Insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply